Search Result "Fas death receptor"
Death Receptors as Targets of Cancer Therapeutics
Journal: Current Cancer Drug Targets
Volume: 4 Issue: 1 Year: 2004 Page: 97-104
Author(s): M. Saeed Sheikh, Ying Huang
Storage, Expression and Function of Fas Ligand, the Key Death Factor of Immune Cells
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2008 Page: 1684-1696
Author(s): Marcus Lettau, Maren Paulsen, Dieter Kabelitz, Ottmar Janssen
Role of FAS in HIV Infection
Journal: Current HIV Research
Volume: 1 Issue: 4 Year: 2003 Page: 405-417
Author(s): Umberto Dianzani, Thea Bensi, Andrea Savarino, Selina Sametti, Manuela Indelicato, Riccardo Mesturini, Annalisa Chiocchetti
Death Receptor Activation-Induced Hepatocyte Apoptosis and Liver Injury
Journal: Current Molecular Medicine
Volume: 3 Issue: 6 Year: 2003 Page: 491-508
Author(s): Xiao-Ming Yin, Wen-Xing Ding
Death Receptor Signaling in Cancer Therapy
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3 Issue: 4 Year: 2003 Page: 253-262
Author(s): Simone Fulda, Klaus-Michael Debatin
ET-18-OCH3 (Edelfosine): A Selective Antitumour Lipid Targeting Apoptosis Through Intracellular Activation of Fas / CD95 Death Receptor
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 2 Year: 2004 Page: 3163-3184
Author(s): Faustino Mollinedo, Consuelo Gajate, Sonsoles Martin-Santamaria, Federico Gago
Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 274-283
Author(s): Consuelo Gajate, Faustino Mollinedo
Heterologous Production of Death Ligandsâ and Death Receptorsâ Extracellular Domains: Structural Features and Efficient Systems
Journal: Protein & Peptide Letters
Volume: 19 Issue: 8 Year: 2012 Page: 867-879
Author(s): Michiro Muraki
Targeting Death Receptors to Fight Cancer: From Biological Rational to Clinical Implementation
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2713-2728
Author(s): S. Mocellin
Therapeutic Targeting of CD95 and the TRAIL Death Receptors
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 294-310
Author(s): Jeannette Gerspach, Klaus Pfizenmaier, Harald Wajant